QTREX Quantum Ltd.
QTEX Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2021โFY2025
Revenue
Total sales reported in the income statement.
$0.3M
vs prior year
Operating margin
Operating income as a share of revenue.
โ4,713.8%
Net income
Profit after all expenses, interest and tax.
โ$13.2M
Free cash flow
Cash from operations minus capital spending.
โ$10.0M
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โ
Market cap
Last close times the latest diluted share count, so it is approximate.
โ
P/E
Last close divided by diluted earnings per share over the last four quarters.
โ
On โ$0.45 EPS (TTM)
What QTREX Quantum Ltd. does
No business description yet.
- Legal name
- QTREX Quantum Ltd.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F ยท Mar 26, 2026
- Accession ยท CIK
- 0001185185-26-001072
0001837493
Revenue and margins
QTREX Quantum Ltd. had $0.3M of revenue in fiscal 2025.
FY21
Revenue โ
FY22
Revenue โ
FY23
Revenue $0.0M
FY24
Revenue $0.0M
FY25
Revenue $0.3M
FY21
Gross โ
Operating โ
Net โ
FCF โ
FY22
Gross โ
Operating โ
Net โ
FCF โ
FY23
Gross โ
Operating โ
Net โ
FCF โ
FY24
Gross โ
Operating โ
Net โ
FCF โ
FY25
Gross 0.7%
Operating โ4,713.8%
Net โ4,574.4%
FCF โ3,447.8%
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY21
Net income โ$17.2M
FY22
Net income โ$15.0M
FY23
Net income โ$11.3M
FY24
Net income โ$11.1M
FY25
Net income โ$13.2M
FY21
Diluted EPS โ$3.24
FY22
Diluted EPS โ$1.39
FY23
Diluted EPS โ$0.93
FY24
Diluted EPS โ$0.60
FY25
Diluted EPS โ$0.45
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY21
Return on capital โ
Return on equity โ72.5%
Return on assets โ
FY22
Return on capital โ
Return on equity โ80.2%
Return on assets โ92.6%
FY23
Return on capital โ
Return on equity โ116.5%
Return on assets โ88.6%
FY24
Return on capital โ
Return on equity โ219.7%
Return on assets โ127.2%
FY25
Return on capital โ
Return on equity โ397.9%
Return on assets โ197.2%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was โ$10.0M in fiscal 2025, โ3,447.8% of revenue. Cash from operations minus capital spending.
FY21
Free cash flow โ$6.9M
FY22
Free cash flow โ$9.5M
FY23
Free cash flow โ$9.9M
FY24
Free cash flow โ$9.5M
FY25
Free cash flow โ$10.0M
FY21
Cash from operations โ$6.7M
Capital spending $0.2M
FY22
Cash from operations โ$9.2M
Capital spending $0.3M
FY23
Cash from operations โ$9.7M
Capital spending $0.2M
FY24
Cash from operations โ$9.4M
Capital spending $0.2M
FY25
Cash from operations โ$9.9M
Capital spending $0.1M
Cash from operations
Capital spending
Dividends, buybacks and share count
QTREX Quantum Ltd. returned โ to shareholders in fiscal 2025. The diluted share count rose 60.0%.
FY21
Dividends โ
Buybacks โ
FY22
Dividends โ
Buybacks โ
FY23
Dividends โ
Buybacks โ
FY24
Dividends โ
Buybacks โ
FY25
Dividends โ
Buybacks โ
Dividends
Buybacks
FY21
Diluted shares 0.01B
FY22
Diluted shares 0.01B
FY23
Diluted shares 0.01B
FY24
Diluted shares 0.02B
FY25
Diluted shares 0.03B
Balance sheet
Cash, debt and the ratios that show how comfortably QTREX Quantum Ltd. can carry it.
FY21
Cash $23.9M
Debt โ
FY22
Cash $13.9M
Debt โ
FY23
Cash $7.3M
Debt โ
FY24
Cash $5.8M
Debt โ
FY25
Cash $3.2M
Debt โ
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $23.9M | $13.9M | $7.3M | $5.8M | $3.2M |
| Interest coverage | โ | โ | โ10.4x | โ | โ |
| Current ratio | โ | 8.7x | 2.6x | 2.0x | 1.6x |
| Quick ratio | โ | 8.7x | 2.6x | 1.9x | 1.3x |
| Total assets | โ | $16.2M | $9.3M | $8.1M | $5.3M |
| Total liabilities | โ | $2.5M | $3.6M | $3.7M | $3.0M |
| Shareholders' equity | $23.7M | $13.6M | $5.7M | $4.3M | $2.3M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 4 | โ / 6 | 1 / 7 | 2 / 7 |
| Accruals ratio | โ | โ35.7% | โ12.5% | โ19.3% | โ50.1% |
| Altman Z'' | โ | โ | โ | โ | โ |
5 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | โ | โ | $0.0M | $0.0M | $0.3M |
| Noninterest expense | โ | โ | $0.7M | โ | โ |
| Gross profit | โ | โ | $0.0M | $0.0M | $0.0M |
| Research and development | $4.1M | $8.2M | $7.3M | $6.3M | $7.5M |
| Operating income | โ$13.0M | โ$14.9M | โ$12.1M | โ$11.3M | โ$13.6M |
| Interest expense | โ | โ | $1.2M | โ | โ |
| Pretax income | โ$17.2M | โ$15.0M | โ$11.3M | โ$11.1M | โ$13.2M |
| Income tax | โ | โ | $0.0M | $0.0M | $0.0M |
| Net income | โ$17.2M | โ$15.0M | โ$11.3M | โ$11.1M | โ$13.2M |
| Diluted EPS | โ$3.24 | โ$1.39 | โ$0.93 | โ$0.60 | โ$0.45 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.02B | 0.03B |
| Cash flow | |||||
| Cash from operations | โ$6.7M | โ$9.2M | โ$9.7M | โ$9.4M | โ$9.9M |
| Capital expenditure | $0.2M | $0.3M | $0.2M | $0.2M | $0.1M |
| Free cash flow | โ$6.9M | โ$9.5M | โ$9.9M | โ$9.5M | โ$10.0M |
| Depreciation and amortization | $0.0M | $0.1M | $0.1M | $0.2M | $0.2M |
| Stock-based compensation | $6.7M | $4.9M | $1.4M | $1.9M | $3.6M |
| Balance sheet | |||||
| Cash and short-term investments | $23.9M | $13.9M | $7.3M | $5.8M | $3.2M |
| Deposits | โ | $7.1M | $0.3M | โ | โ |
| Current assets | โ | $14.5M | $7.8M | $6.8M | $4.4M |
| Current liabilities | โ | $1.7M | $3.0M | $3.4M | $2.8M |
| Inventory | โ | โ | โ | $0.4M | $0.7M |
| Property and equipment, net | โ | $0.4M | $0.5M | $0.5M | $0.5M |
| Total assets | โ | $16.2M | $9.3M | $8.1M | $5.3M |
| Total liabilities | โ | $2.5M | $3.6M | $3.7M | $3.0M |
| Shareholders' equity | $23.7M | $13.6M | $5.7M | $4.3M | $2.3M |
| Margins | |||||
| Gross margin | โ | โ | โ | โ | 0.7% |
| Operating margin | โ | โ | โ | โ | โ4,713.8% |
| EBITDA margin | โ | โ | โ | โ | โ4,661.9% |
| Net margin | โ | โ | โ | โ | โ4,574.4% |
| FCF margin | โ | โ | โ | โ | โ3,447.8% |
| Returns | |||||
| Return on capital employed | โ | โ102.7% | โ191.8% | โ239.7% | โ541.2% |
| Return on equity | โ72.5% | โ80.2% | โ116.5% | โ219.7% | โ397.9% |
| Return on assets | โ | โ92.6% | โ88.6% | โ127.2% | โ197.2% |
| Return on tangible equity | โ72.5% | โ109.9% | โ196.7% | โ255.7% | โ569.1% |
| Growth | |||||
| Share count change | โ | 103.4% | 12.1% | 53.1% | 60.0% |
| Financial health | |||||
| Interest coverage | โ | โ | โ10.4x | โ | โ |
| Current ratio | โ | 8.7x | 2.6x | 2.0x | 1.6x |
| Quick ratio | โ | 8.7x | 2.6x | 1.9x | 1.3x |
| Capital allocation | |||||
| Capex / revenue | โ | โ | โ | โ | 35.6% |
| Stock comp / revenue | โ | โ | โ | โ | 1,237.0% |
| Quality scores | |||||
| Piotroski F-score | โ | โ | โ | 1.0 | 2.0 |
| Accruals ratio | โ | โ35.7% | โ12.5% | โ19.3% | โ50.1% |
Source: SEC EDGAR XBRL filings (CIK 0001837493). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.